December 28, 2014 11:13 PM ET

Healthcare Equipment and Supplies

Company Overview of Acelity L.P. Inc.

Company Overview

Kinetic Concepts Inc. produces surgical healing and hospital patient-mobility equipment, including a tissue-repair therapy used in hospitals in the U.S. and worldwide for acute care and serious trauma. Its wound-care and tissue-repair system is used in pulmonary care, for post-cardiac-arrest complications in the intensive-care unit, and for other types of wound treatment including failed surgical closures, amputations, and serious pressure ulcers. The system works by using a vacuum-assisted closure technology. A second product is a line of hospital equipment that provides mobility to patients who cannot move because of pulmonary complications or due to obesity. Its bariatric-care products pr...

12930 West Interstate 10

San Antonio, TX 78249

United States

Founded in 1976

5,550 Employees

Phone:

210-524-9000

Key Executives for Acelity L.P. Inc.

principal Executive Officer
Age: 48
Chief Financial Officer and Executive Vice President
Age: 51
Senior Vice President of Operations
Age: 54
President of Developed Markets
Group President of Businesses and Innovation
Compensation as of Fiscal Year 2014.

Acelity L.P. Inc. Key Developments

Acelity L.P. Inc. Appoints Gaurav S. Agarwal as Group President, Businesses and Innovation

Acelity L.P. Inc. announced the appointment of Gaurav S. Agarwal as Group President, Businesses and Innovation, a newly-created role on the Acelity senior leadership team reporting directly to Joe Woody, President & CEO. In this role, Gaurav will lead the strategic direction for all Acelity businesses, including Advanced Wound Therapeutics and Regenerative Medicine. Gaurav will assume commercial responsibility for Acelity’s diverse product portfolio of innovative healing solutions and regenerative and reconstructive tissue matrices. He will drive Acelity’s product portfolio expansion to offer new and innovative solutions for the future of negative pressure therapies and adjacent technologies. Gaurav will oversee Acelity’s innovation pipeline, product portfolio strategy and execution, in addition to North American commercial operations. He will be responsible for creating and managing multiple development platforms across the business to continue to bring highly differentiated products, such as the CelluTome Epidermal Harvesting System, to market. Gaurav brings to Acelity nearly two decades of global business management in the healthcare industry. Most recently, he served as President, Orthopaedic Reconstruction for the Advanced Surgical Devices Division at Smith & Nephew.

Acelity L.P. Inc. Appoints Thomas Casey as Executive Vice President and Chief Financial Officer

Acelity L.P. Inc. announced the appointment of Thomas Casey, a well-respected financial leader, as Executive Vice President and Chief Financial Officer. Tom brings to Acelity 30 years of financial accounting, reporting, planning and analysis experience, which include nearly two decades of roles in senior leadership. Most recently, Tom served as Executive Vice President and CFO at Clear Channel where he was responsible for overseeing all financial, IT and shared services activities for the global media and entertainment company with more than $6 billion in annual revenue.

Acelity L.P. Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Acelity L.P. Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the period, the company reported total revenue of $488,651,000 compared to $440,561,000 a year ago. Operating earnings were $90,620,000 compared to operating loss of $369,866,000 a year ago. Loss from continuing operations before income tax benefit was $2,603,000 compared to $486,825,000 a year ago. Loss from continuing operations was $1,837,000 compared to $398,306,000 a year ago. Net loss was $1,837,000 compared to $398,561,000 a year ago. Total adjusted EBITDA was $194,074,000 compared to $191,140,000 a year ago. The increase in revenues during the third quarter was due to the acquisition of Systagenix and a significant increase in volumes and customer win back activity in devices business. Adjusted EBITDA was higher in the third quarter compared to the same quarter last year, primarily due to the acquisition of Systagenix, volume growth from AWT devices and growth in breast reconstruction, focus products and emerging markets. The company generated $44 million of cash from operating activities, which was lower than the third quarter of 2013, due primarily to the first installment of Wake Forest settlement payments, which they made in July in the amount of $80 million. For the nine months, the company reported total revenue of $1,401,361,000 compared to $1,289,124,000 a year ago. Operating earnings were $15,799,000 compared to operating loss of $323,203,000 a year ago. Loss from continuing operations before income tax benefit was $313,012,000 compared to $648,167,000 a year ago. Loss from continuing operations was $200,937,000 compared to $503,624,000 a year ago. Net loss was $200,937,000 compared to $505,923,000 a year ago. Net cash provided by operating activities was $105,031,000 compared to $135,495,000 a year ago. Additions to property, plant and equipment was $46,760,000 compared to $59,868,000 a year ago. Total adjusted EBITDA was $518,956,000 compared to $524,884,000 a year ago.

Similar Private Companies By Industry

Company Name Region
Ortho Technology, Inc. United States
VivaRay, Inc. United States
Life-Tech, Inc. United States
Praxair Healthcare Services, Inc. United States
AVYAYAH Technologies LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Acelity L.P. Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.